/lifesciences?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Life Sciences Copyright 2025 sa¹ú¼Ê´«Ã½. en-US Wed, 25 Jun 2025 20:59:16 +0000 /lifesciences/articles/2357529?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357529 A California federal jury has found the former CEO of a blood bank business liable for securities fraud, agreeing with the U.S. Securities and Exchange Commission that the executive defrauded retirees out of more than $10 million by promising them returns he knew he could not deliver. Wed, 25 Jun 2025 20:56:06 +0000 /lifesciences/articles/2357343?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357343 Cigna has launched an antitrust suit in New York federal court accusing Bristol-Myers Squibb Co. and its Celgene subsidiary of fraudulently obtaining patents, filing sham litigation and paying off generic-drug makers to maintain a monopoly on their blockbuster blood-cancer drug Pomalyst. Wed, 25 Jun 2025 20:25:34 +0000 /lifesciences/articles/2357344?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357344 Minovia Therapeutics Ltd., an Israeli startup developing treatments for age-related decline, plans to go public in the U.S. at a $180 million valuation by merging with special purpose acquisition company Launch One Acquisition Corp., both parties announced Wednesday. Wed, 25 Jun 2025 19:57:25 +0000 /lifesciences/articles/2357474?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357474 The Federal Circuit on Wednesday denied a bid to revive a patent infringement case from a man who says Google's products use aspects of his threat-detection technology. Wed, 25 Jun 2025 18:53:49 +0000 /lifesciences/articles/2356917?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356917 Aetna and its owner, CVS Health Corp., say a medical laboratory's revamped lawsuit alleging that $20.6 million in invoices remain unpaid fares no better than an earlier version that led a Connecticut federal judge to show the lab the courthouse door earlier this year. Wed, 25 Jun 2025 18:17:39 +0000 /lifesciences/articles/2355159?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2355159 Halfway through 2025, now is a good time for companies to thoroughly evaluate their trade secret portfolios and follow eight steps to reassess protection processes for confidential information, says Robert Jensen at Wolf Greenfield. Wed, 25 Jun 2025 17:43:49 +0000 /lifesciences/articles/2357093?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357093 A class action filed two days after the U.S. Food and Drug Administration announced plans to remove ingestible fluoride prescription drug products for children from the market may be the tip of the iceberg in terms of the connection between government pronouncements on safety and their immediate use as evidence in lawsuits, says Rachel Turow at Skadden. Wed, 25 Jun 2025 16:25:07 +0000 /lifesciences/articles/2356852?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356852 Connecticut's Griffin Hospital says Novo Nordisk's attempt to score sanctions in a lawsuit about insulin pen contamination should be rejected because no law requires the healthcare facility to lay out its adversary's possible defenses when pleading its claims. Wed, 25 Jun 2025 16:03:39 +0000 /lifesciences/articles/2357298?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357298 K&L Gates LLP said Wednesday it has brought on a pharmaceutical attorney from Powers Pyles Sutter & Verville PC who worked for nearly a decade as a pharmacist and has handled pharmacy law matters for more than 15 years. Wed, 25 Jun 2025 13:59:49 +0000 /lifesciences/articles/2355169?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2355169 EisnerAmper has expanded its international tax services group with a new partner who helps individual and corporate clients navigate legislation, regulatory risks and compliance obligations. Wed, 25 Jun 2025 13:25:23 +0000 /lifesciences/articles/2348925?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2348925 Law schools don’t spend sufficient time dispelling certain myths that prevent young lawyers from exploring new business opportunities, but by dismissing these misguided beliefs, even an introverted first-year associate with a small network of contacts can find long-term success, says Ronald Levine at Herrick Feinstein. Tue, 24 Jun 2025 20:38:41 +0000 /lifesciences/articles/2356760?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356760 A water purification company that's faced a bevy of product liability lawsuits over a disinfectant product needs to pay only one $5 million retained limit before a Chubb unit's coverage obligations under umbrella policies potentially kick in for one of the underlying cases, a Minnesota federal court ruled. Tue, 24 Jun 2025 20:38:28 +0000 /lifesciences/articles/2356590?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356590 A Connecticut federal judge won't toss an amended class action claiming a healthcare technology company misled investors about a data platform it claimed to operate that didn't actually exist, ruling that statements about the platform's capabilities are not inactionable, forward-looking statements. Tue, 24 Jun 2025 19:24:04 +0000 /lifesciences/articles/2357023?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2357023 Abbott Laboratories was sued Tuesday in Illinois federal court by a former worker alleging the company's onboarding materials asked for his family's medical history in violation of a state law aimed at protecting residents' genetic information. Tue, 24 Jun 2025 18:52:18 +0000 /lifesciences/articles/2356845?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356845 California enforcers on Monday asked the Ninth Circuit to overturn a district court's decision that a state law restricting "reverse payment" settlements between brand-name and generic-drug makers cannot be used to regulate deals that were struck outside the Golden State. Tue, 24 Jun 2025 16:28:04 +0000 /lifesciences/articles/2356562?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356562 An AIG unit urged the Illinois Supreme Court to find that a permit or regulation allowing a company to discharge toxins into the environment has no bearing on the application of a pollution exclusion, saying "pollution is pollution" regardless of government authorization. Tue, 24 Jun 2025 15:26:54 +0000 /lifesciences/articles/2356766?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356766 Johnson & Johnson Services Inc. told a New Jersey federal court this week that a former in-house data privacy attorney suing the pharmaceuticals giant for discrimination failed to plead any facts supporting her allegation that the company passed her over for a job in favor of a less qualified candidate. Tue, 24 Jun 2025 15:24:40 +0000 /lifesciences/articles/2356985?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356985 A Massachusetts federal judge on Tuesday denied the Trump administration's request to stay a recent order that it resume processing National Institutes of Health grant applications and releasing funds, warning that even one more day of delay would lead to irreparable harm. Tue, 24 Jun 2025 15:01:19 +0000 /lifesciences/articles/2356572?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2356572 The Tenth Circuit has sided with a district court's decision dismissing a bid by the former general counsel of a medical device company to have Loeb & Loeb LLP sanctioned for bringing what he said was a baseless lawsuit against him on behalf of his former employer. Tue, 24 Jun 2025 14:50:00 +0000 /lifesciences/articles/2353802?utm_source=rss&utm_medium=rss&utm_campaign=section /lifesciences/articles/2353802 Law360 Healthcare Authority reviews key trends that helped shape dealmaking activity in the healthcare industry so far this year.